Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

<p>Simvastatin responsive genes</p>

Збережено в:

Бібліографічні деталі
Автор:	Gia-Buu Tran (16437051) (author)
Інші автори:	Jane Ding (16437054) (author), Bingwei Ye (16437057) (author), Mengling Liu (16437060) (author), Yajie Yu (16437063) (author), Yunhong Zha (16437066) (author), Zheng Dong (16437069) (author), Kebin Liu (14939874) (author), Sunil Sudarshan (16437072) (author), Han-Fei Ding (16437075) (author)
Опубліковано:	2025
Предмети:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Drug Targets Metabolism Metabolic pathways Pediatric Cancers Small Molecule Agents
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
за авторством: Haowen Jiang (14963613)
Опубліковано: (2025)

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
за авторством: Haowen Jiang (14963613)
Опубліковано: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
за авторством: Haowen Jiang (14963613)
Опубліковано: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
за авторством: Haowen Jiang (14963613)
Опубліковано: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
за авторством: Snehanshu Chowdhury (14957031)
Опубліковано: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table 1 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
за авторством: David Olayinka Kamson (16617218)
Опубліковано: (2025)

Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
за авторством: David Olayinka Kamson (16617218)
Опубліковано: (2025)

Effects of <i>T. gondii</i> infection on rat gut microbiota diversity.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
за авторством: William Kelly (15439117)
Опубліковано: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
за авторством: William Kelly (15439117)
Опубліковано: (2025)

Table S1 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
за авторством: Thomas Farge (15112135)
Опубліковано: (2025)

Table S2 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
за авторством: Thomas Farge (15112135)
Опубліковано: (2025)

Table S3 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
за авторством: Thomas Farge (15112135)
Опубліковано: (2025)

Table S4 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
за авторством: Thomas Farge (15112135)
Опубліковано: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
за авторством: Evangeline R. Jackson (15558808)
Опубліковано: (2025)

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
за авторством: Sebastian Johannes Schober (14971891)
Опубліковано: (2025)

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
за авторством: Sebastian Johannes Schober (14971891)
Опубліковано: (2025)

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
за авторством: Sebastian Johannes Schober (14971891)
Опубліковано: (2025)

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
за авторством: Sebastian Johannes Schober (14971891)
Опубліковано: (2025)

Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
за авторством: Sebastian Johannes Schober (14971891)
Опубліковано: (2025)

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
за авторством: Chun-Miao Deng (15618965)
Опубліковано: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
за авторством: Gwo Yaw Ho (14961416)
Опубліковано: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
за авторством: Laura Privitera (16015972)
Опубліковано: (2025)

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
за авторством: Elizabeth R. Tucker (15053624)
Опубліковано: (2025)

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
за авторством: Elizabeth R. Tucker (15053624)
Опубліковано: (2025)

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
за авторством: Elizabeth R. Tucker (15053624)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_lv9rohnkbu4j44oga9h1u6ap77